Prostate Cancer Surpasses Breast Cancer in UK Diagnoses

Prostate cancer has officially become the most frequently diagnosed cancer in the UK, overtaking breast cancer, as reported by a prominent charity.

In 2022, there were approximately 64,425 prostate cancer diagnoses compared to 61,640 new breast cancer cases, derived from an analysis of NHS statistics by Prostate Cancer UK.

The analysis pointed out that men in different regions are diagnosed at varying stages. For instance, 31% of men in Scotland were diagnosed at stage 4, while this figure was 21% for men in England.

It’s estimated that about one in eight men in the UK will face a prostate cancer diagnosis in their lifetime, resulting in roughly 12,200 deaths annually due to the disease.

Furthermore, the statistics show that one in four black men will be diagnosed with prostate cancer during their lives, and they are also at a greater risk of being diagnosed at a later stage compared to their white counterparts.

Prostate Cancer UK highlighted an apparent “postcode lottery” in terms of testing and diagnoses, noting that rates of prostate specific antigen (PSA) testing are highest in the southeast of England but much lower in the northwest.

Men residing in more deprived areas are 29% more likely to be diagnosed with advanced cancer than those living in wealthier locations.

Chiara De Biase, director of health services, equity, and improvement at Prostate Cancer UK, remarked that awareness campaigns have significantly contributed to this increased diagnosis rate. She stated, “More men than ever are being diagnosed and treated.”

“While prostate cancer has become the most prevalent cancer in the UK, unfair disparities still exist based on geographic location. We need an early detection program to tackle these regional inequities,” De Biase emphasized.

She added that extensive risk-awareness campaigns, such as a national initiative launched in February 2022 in collaboration with the NHS, aim to encourage men to check their risk of prostate cancer.

Additionally, public figures discussing their own prostate cancer experiences, such as Bill Turnbull, Nick Owen, and Colin McFarlane, have helped motivate men to seek testing.

Last year marked the first time prostate cancer was reported as the most common cancer diagnosis in England, and recent statistics from Scotland, Wales, and Northern Ireland facilitated a broader UK analysis. In Scotland alone, there were 5,608 diagnoses, reflecting a 30% increase from prior data.

Ian Walker, executive director of policy at Cancer Research UK, pointed out that these numbers could be influenced by overdiagnosis, where PSA tests might detect cancers in men who show no symptoms.

A panel of expert government health advisors noted in November that broad prostate cancer screening isn’t expected to become widely available for most men in the UK.

They proposed a targeted screening program for men with BRCA1 or BRCA2 faulty gene variants, who face a higher risk of aggressive cancers earlier in life. For this group, screening could occur every two years, from ages 45 to 61.

This recommendation comes despite calls from campaigners and charities advocating for screening access for high-risk demographics, including black men and those with family histories of the disease.

A spokesperson from the Department of Health and Social Care mentioned ongoing efforts to enhance outcomes for men with prostate cancer, emphasizing that many men in deprived communities are diagnosed at more advanced stages, making treatment more challenging.

“Recently, the NHS expanded access to abiraterone, a treatment that significantly improves survival rates. We’re also making strides in reducing cancer waiting times,” the spokesperson stated, highlighting that 213,000 more patients received timely diagnoses for suspected cancer over the past year.